🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Diabetic Retinopathy (DR)

"My Eyes, My Light": Amar Chokh, Amar Alo NCT07135570n/a1 site📍 Char Fasson Data Yakka, Inc. · Tests: Multimodal Screening for Eye Disease, cataract surgery Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening NCT06843499NA1 site📍 Taipei National Taiwan University Hospital · Tests: The VeriSee AI-assisted diagnostic system, Data collection from the patient's clinical history Diabetic Retinopathy Prevalence And Risk Factors NCT07468058n/a1 site📍 Da Nang Da Nang Family General Hospital · Tests: fundus examination and optical coherence tomography (OCT) Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE) NCT07296952NA1 site📍 Chicago University of Illinois at Chicago · Tests: PRONTO-EYE Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy NCT07351786n/a1 site📍 Alexandria Sara A Belal Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales NCT06914778n/a1 site📍 Llanelli Hywel Dda Health Board · Tests: Blood draw for the laboratory assessment, Urine sample To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy NCT07634991Phase 42 sites📍 Cairo📍 Cairo Ain Shams University · Tests: N Acetyl cysteine, 1200mg (high dose) Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics NCT07069647NA1 site📍 Taipei National Taiwan University Hospital · Tests: VeriSee AI-assisted screening tools for diabetic retinopathy and age-related macular degeneration, Standard fundus phot… Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus NCT07378956NA1 site📍 Incheon VUNO Inc. · Tests: VUNO Med®-Fundus AI™ Assessment of AI Program 'DRISTi' as a Screening Tool NCT07222293n/a2 sites📍 Oxford📍 Raleigh Artelus AI · Tests: Fundus Image Grading Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab NCT07520045NA1 site📍 Osijek Osijek University Hospital · Tests: Faricimab, Biosimilar ranibizumab The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma NCT06593405EARLY Phase 11 site📍 Worcester MCPHS University · Tests: occupational therapy interventions for low vision care Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply Side NCT06968637NA2 sites📍 Dinajpur Sadar📍 Dinajpur District Orbis · Tests: care recommendations Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment NCT07500324NA1 site📍 Roma Fondazione G.B. Bietti, IRCCS · Tests: Biological Sample Collection Analysis of DR Progression to Identify Risks and Need for Treatment NCT07417410n/a1 site📍 Portugal Association for Innovation and Biomedical Research on Light… Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side NCT06968611NA2 sites📍 Dinajpur📍 Dinajpur Sadar Orbis · Tests: Education/information of risk, Free eye glasses Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy NCT07844317n/a1 site📍 Jacksonville Digital Diagnostics, Inc. · Tests: SaMD intended for the detection of diabetic retinopathy in adults with diabetes., An AI/ML-based Software as a Medical … Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR) NCT03403686n/a1 site📍 Birmingham University of Alabama at Birmingham · Tests: blood draw
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy